Your browser doesn't support javascript.
loading
Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer.
Sakashita, Takuya; Yanagitani, Noriko; Koike, Sumie; Low, Siew-Kee; Takagi, Satoshi; Baba, Satoko; Takeuchi, Kengo; Nishio, Makoto; Fujita, Naoya; Katayama, Ryohei.
Afiliação
  • Sakashita T; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Yanagitani N; Department of Computational Biology and Medical Science, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
  • Koike S; Science Enablement Department, Science & Data Analytics Division, Research & Development, AstraZeneca K.K, Osaka, Japan.
  • Low SK; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Takagi S; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Baba S; Cancer Precision Medicine Center, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Takeuchi K; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Nishio M; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Fujita N; Pathology Project for Molecular Targets, the Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Katayama R; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Cancer Sci ; 113(11): 3888-3900, 2022 Nov.
Article em En | MEDLINE | ID: mdl-35950895
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Receptor Tipo 3 de Fator de Crescimento de Fibroblastos / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Receptor Tipo 3 de Fator de Crescimento de Fibroblastos / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão